Analyst was pretty positive about OPK and its prospects. With Frost buying so many shares every week, it sure looks like something very good is in the near future. With so many shorts needing to cover on positive news, this stock could really skyrocket. IMHO.
Maybe we will hear something good at the upcoming earnings announcement. Everything I have read so far about their trial results has been positive, so I hope we get some good news. I too started buying when the stock was higher. I guess my cost is in the 10's. If we get good news, I believe the stock will bounce much higher than that. IMHO.
indirectly through entities he controls. This guy is either throwing his money away, or he knows that this investment is the best one he can make. If I was short, I would run to cover!!! IMHO.
I don't see the big reason to short OPK. They have late stage drugs in development, and they have worldwide sales of various drugs that bring in decent revenue. With Frost appearing to be buying hundreds of thousands of shares hand over fist, shorts could be in for a big hurt. Seems like there are much better shares to short in my opinion.
He seems to be buying shares like crazy. Now if his name was Icahn, Opk would be selling in the twenties. I actually think Frost is much smarter than CI, especially when it comes to drug companies. Good luck.
I hope you got some as did I. Let's see if CEMP runs up into the release of the trial results.
Hope Grassley continues to search for the leak. If he and his party have any integrity, it shouldn't matter whether the leak was from a Democrat or someone for Grassley's own party, possibly a former aid of Grassley. What's best for America is what is at stake, but I bet politics will rule the day as usual! We shall see.
I feel your pain. I have a few thousand shares of CEMP, and that has taken a beating also, but not as bad as CLDX. I also own a fair chunk of OPK, but that has held its own fairly well with Dr. Frost buying thousands of shares a few times each week. If CLDX's science is solid, it should bounce back, but who knows when. I hope things turn around for longs and the cancer patients who could use these drugs!
Investing in bio-techs can provide big rewards or big hurts. The whole sector has been brought to its knees. If there is a near term positive catalyst, the slide should reverse. With no news on the horizon concerning trial results, specific bio-techs are at the mercy of the market.
The stock drop hurts for longs, but the company still has all the prospects it had before.
I agree about a buying opportunity. Key usually bounces back pretty quickly in cases like this. I'm tapped out right now, but if I had some extra cash to invest, Key would be very attractive at this level. IMHO.
Everything I have read so far looks good for Cemp's antibiotic. With such a dire need for new antibiotics, Cemp seems attractively priced down here. Besides, how long will it take for a larger pharma to notice the fire sale price and take an interest. Cemp could be a very attractive takeover candidate. IMHO.
Mongolia reaches an agreement with the company. With so many jobs at stake, and with Mongolia holding a stake in the company, a deal should be a no-brainer.
Based on what I saw on the Key website, it appears that Key has beaten expectations by reportedly posting earnings of 27 cents per share. I also saw a news article saying that Key missed earnings, but I think Key's release would be the most accurate. IMHO.